Amphetamine 10mg

Drug Amneal Pharmaceuticals LLC
Total Payments
$184,382
Transactions
7
Doctors
0
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $184,382 7 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $184,382 7 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A Study to Evaluate the Relative Bioavailability of a Test Formulation of Amphetamine Sulfate Tablets USP, 10mg [CII] (Amneal Pharmaceuticals) Compared to EVEKEO (amphetamine sulfate tablets, USP) CII, 10mg (Arbor Pharmaceuticals, LLC) in Healthy Adult Subjects under Fasted Conditions (11649726) Amneal Pharmaceuticals LLC $108,460 0
A Study to Evaluate the Relative Bioavailability of a Test Formulation of Amphetamine Sulfate Tablets USP, 10mg [CII] (Amneal Pharmaceuticals) Compared to EVEKEO (amphetamine sulfate tablets, USP) CII, 10mg (Arbor Pharmaceuticals, LLC) in Healthy Adult Subjects under Fed Conditions (11649727) Amneal Pharmaceuticals LLC $75,922 0

Top Doctors Receiving Payments for Amphetamine 10mg

Doctor Specialty Location Total Records
Unknown Pittsburgh, PA $184,382 7

About Amphetamine 10mg

Amphetamine 10mg is a drug associated with $184,382 in payments to 0 healthcare providers, recorded across 7 transactions in the CMS Open Payments database. The primary manufacturer is Amneal Pharmaceuticals LLC.

Payment data is available from 2017 to 2017. In 2017, $184,382 was paid across 7 transactions to 0 doctors.

The most common payment nature for Amphetamine 10mg is "Unspecified" ($184,382, 100.0% of total).

Amphetamine 10mg is associated with 2 research studies, including "A Study to Evaluate the Relative Bioavailability of a Test Formulation of Amphetamine Sulfate Tablets USP, 10mg [CII] (Amneal Pharmaceuticals) Compared to EVEKEO (amphetamine sulfate tablets, USP) CII, 10mg (Arbor Pharmaceuticals, LLC) in Healthy Adult Subjects under Fasted Conditions (11649726)" ($108,460).